These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1213 related articles for article (PubMed ID: 8882670)

  • 1. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus.
    van Cleeff MR; Chum HJ
    Int J Epidemiol; 1995 Jun; 24(3):637-42. PubMed ID: 7672908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in Mwanza, Tanzania.
    Range N; Friis H; Mfaume S; Magnussen P; Chanualucha J; Kilale A; Mugomela A; Andersen AB
    Tanzan J Health Res; 2012 Oct; 14(4):243-9. PubMed ID: 26591721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastion I; Carter R; Jelfs P; Keehner T; Sievers A
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):154-61. PubMed ID: 22010508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The point of view of a high prevalence country: Malawi.
    Nyangulu DS
    Bull Int Union Tuberc Lung Dis; 1991 Dec; 66(4):173-4. PubMed ID: 1687509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology-based Analysis of Characteristics of Dual Infection of Tuberculosis /Acquired Immune Deficiency Syndrome (AIDS) and Drug Resistance Mechanism of Related Genes.
    Yang J; Zheng X; Zhang S; Wang H
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 68(2):109-118. PubMed ID: 35869708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 infection as a risk factor for the development of tuberculosis: a case-control study in Tanzania.
    Van den Broek J; Borgdorff MW; Pakker NG; Chum HJ; Klokke AH; Senkoro KP; Newell JN
    Int J Epidemiol; 1993 Dec; 22(6):1159-65. PubMed ID: 8144300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in Poland in 2016.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2018; 72(2):189-205. PubMed ID: 30111079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
    Mutayoba BK; Ershova J; Lyamuya E; Hoelscher M; Heinrich N; Kilale AM; Range NS; Ngowi BJ; Ntinginya NE; Mfaume SM; Nkiligi E; Doulla B; Lyimo J; Kisonga R; Kingalu A; Lema Y; Kondo Z; Pletschette M
    Trop Med Int Health; 2022 Oct; 27(10):891-901. PubMed ID: 36089572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam.
    Mai TQ; Van Anh NT; Hien NT; Lan NH; Giang DC; Hang PTT; Lan NTN; Marais BJ; Sintchenko V
    J Glob Antimicrob Resist; 2017 Sep; 10():154-160. PubMed ID: 28743648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey.
    Lukoye D; Adatu F; Musisi K; Kasule GW; Were W; Odeke R; Kalamya JN; Awor A; Date A; Joloba ML
    PLoS One; 2013; 8(8):e70763. PubMed ID: 23936467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
    Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
    BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.